In mice lacking the KLHL1 gene, blocking T-type calcium channels with a specific drug restores the ability of leptin to activate brain cells that control appetite, showing that excessive electrical activity in these cells—not a broken leptin receptor—causes leptin resistance.
See the scientific wording
Pharmacological blockade of T-type calcium channels using NNC-550396 at a concentration of 30 nM restores leptin-induced electrical excitability in hypothalamic POMC neurons in KLHL1 knockout mice, indicating that hyperexcitability, rather than leptin receptor dysfunction, is the primary mechanism underlying leptin resistance in this model.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Case-Control StudyAnimal2021
In obese mice with a genetic glitch, their brain cells that tell us we're full became too hyperactive and ignored the fullness hormone. When scientists gently slowed down these overactive cells, the hormone worked again—proving the problem wasn't a broken signal, but too much electrical noise.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When KLHL1 is missing, brain cells that signal fullness produce too many T-type calcium channels. These channels let in too much calcium at rest, making the cells fire constantly and too loudly. Because they are already firing at maximum capacity, the hormone leptin cannot make them fire any more, so the brain does not register fullness. Blocking these extra channels brings the cells back to a normal resting state, allowing leptin to work again.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In mice lacking the KLHL1 gene, blocking T-type calcium channels with a specific drug restores the ability of leptin to activate brain cells that control appetite, showing that excessive electrical activity in these cells—not a broken leptin receptor—causes leptin resistance.
Mechanism
1 studyWhen KLHL1 is missing, brain cells that signal fullness become overactive because they make too many T-type calcium channels. These channels keep the cells firing nonstop, so the fullness hormone leptin can't make them fire any more. Blocking these extra channels brings the cells back to a normal state, letting leptin work again.
When KLHL1 is missing, brain cells that signal fullness produce too many T-type calcium channels. These channels let in too much calcium at rest, making the cells fire constantly and too loudly. Because they are already firing at maximum capacity, the hormone leptin cannot make them fire any more, so the brain does not register fullness. Blocking these extra channels brings the cells back to a normal resting state, allowing leptin to work again.
Loss of KLHL1 protein removes its inhibitory regulation of CaV3.1 T-type calcium channels, leading to their compensatory overexpression in hypothalamic POMC neurons
Overexpressed CaV3.1 channels increase T-type current density and shift voltage dependence to favor sustained calcium influx at resting membrane potential
Enhanced window current at resting membrane potential causes persistent depolarization and elevated basal firing rate in POMC neurons
Elevated basal excitability prevents further depolarization by leptin-activated TRPC1/5 channels, rendering POMC neurons electrically unresponsive to leptin
Partial pharmacological blockade of CaV3.1 channels reduces basal excitability to sub-threshold levels, restoring the capacity for leptin to induce depolarization and electrical activation
Evidence from Studies
Supporting (1)
Community contributions welcome
Genetic Deletion of KLHL1 Leads to Hyperexcitability in Hypothalamic POMC Neurons and Lack of Electrical Responses to Leptin
In obese mice with a genetic glitch, their brain cells that tell us we're full became too hyperactive and ignored the fullness hormone. When scientists gently slowed down these overactive cells, the hormone worked again—proving the problem wasn't a broken signal, but too much electrical noise.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of T-Type Calcium Channel Blockade Effects on Leptin Sensitivity in Genetic Mouse Models of Obesity
Systematic review and meta-analysis of all peer-reviewed studies comparing NNC-550396 or other T-type calcium channel blockers to vehicle control in KLHL1 knockout mice, measuring POMC neuron excitability, leptin signaling markers, and food intake over 1–4 weeks.
Double-Blind, Placebo-Controlled Trial of NNC-550396 on Hypothalamic POMC Neuron Excitability in KLHL1 Knockout Mice
Randomized, double-blind assignment of KLHL1 knockout mice to NNC-550396 (30 nM) or vehicle infusion, with blinded electrophysiological measurement of POMC neuron firing rate before and after leptin application over 24–72 hours.
Longitudinal Study of Leptin Resistance and POMC Neuron Excitability in KLHL1 Knockout Mice Treated with NNC-550396
Prospective observation of KLHL1 knockout mice receiving NNC-550396 (30 nM) over 4 weeks, measuring daily food intake, body weight, and weekly POMC neuron excitability and leptin receptor phosphorylation.
Patch-Clamp Electrophysiology of Hypothalamic POMC Neurons from KLHL1 Knockout Mice Treated with NNC-550396 and Leptin
Ex vivo patch-clamp recordings from hypothalamic slices of KLHL1 knockout mice, comparing POMC neuron firing rates before and after leptin application with and without 30 nM NNC-550396 pre-treatment.
Behavioral and Electrophysiological Effects of NNC-550396 in KLHL1 Knockout Mice with Leptin Resistance
KLHL1 knockout mice treated with NNC-550396 (30 nM) via intracerebroventricular infusion for 7 days, with measurements of food intake, body weight, plasma leptin, and in vivo POMC neuron activity via fiber photometry.